Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients.
J Clin Oncol. 2000 Feb;18(3):562-73. doi: 10.1200/JCO.2000.18.3.562.
J Clin Oncol. 2000.
PMID: 10653871
Clinical Trial.
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.
Soulié P, Bensmaïne A, Garrino C, Chollet P, Brain E, Fereres M, Jasmin C, Musset M, Misset JL, Cvitkovic E.
Soulié P, et al. Among authors: bensmaine a.
Eur J Cancer. 1997 Aug;33(9):1400-6. doi: 10.1016/s0959-8049(97)00122-6.
Eur J Cancer. 1997.
PMID: 9337681
Clinical Trial.
Item in Clipboard
Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer.
Gandia D, Wibault P, Guillot T, Bensmaine A, Armand JP, Marandas P, Luboinski B, Cvitkovic E.
Gandia D, et al. Among authors: bensmaine a.
Head Neck. 1993 Jan-Feb;15(1):8-15. doi: 10.1002/hed.2880150103.
Head Neck. 1993.
PMID: 7677989
Item in Clipboard
Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell cancer: a prospective validation.
Janot F, Cvitkovic E, Piekarski JD, Sigal R, Armand JP, Bensmaine A, Luboinski B.
Janot F, et al. Among authors: bensmaine a.
Head Neck. 1993 May-Jun;15(3):222-9. doi: 10.1002/hed.2880150309.
Head Neck. 1993.
PMID: 8491586
Item in Clipboard
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators.
Richardson PG, et al. Among authors: bensmaine a.
Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13.
Lancet Oncol. 2019.
PMID: 31097405
Clinical Trial.
Item in Clipboard
Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma.
Richardson PG, Hofmeister CC, Raje NS, Siegel DS, Lonial S, Laubach J, Efebera YA, Vesole DH, Nooka AK, Rosenblatt J, Doss D, Zaki MH, Bensmaine A, Herring J, Li Y, Watkins L, Chen MS, Anderson KC.
Richardson PG, et al. Among authors: bensmaine a.
Leukemia. 2017 Dec;31(12):2695-2701. doi: 10.1038/leu.2017.173. Epub 2017 Jun 2.
Leukemia. 2017.
PMID: 28642620
Free PMC article.
Clinical Trial.
Item in Clipboard
Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma.
Richardson PG, Hofmeister CC, Raje NS, Siegel DS, Lonial S, Laubach J, Efebera YA, Vesole DH, Nooka AK, Rosenblatt J, Doss D, Zaki MH, Bensmaine A, Herring J, Li Y, Watkins L, Chen MS, Anderson KC.
Richardson PG, et al. Among authors: bensmaine a.
Leukemia. 2018 Oct;32(10):2305. doi: 10.1038/s41375-018-0235-5.
Leukemia. 2018.
PMID: 30218008
Free PMC article.
Item in Clipboard
Cite
Cite